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ABSTRACT The "zinc finger" model [Miller, J.,
McLachlan, A. D. & Klug, A. (1985) EMBO J. 4, 1609-1614;
Brown, R. S., Sander, C. & Argos, P. (1985) FEBS Left. 186,
271-274] makes both specific structural and specific functional
predictions about zinc finger consensus sequences that can be
tested with a combination of genetic, molecular biological, and
biophysical techniques. The yeast transcription factor ADR1
contains two adjacent zinc finger domains; genetic and deletion
analyses showed that amino acid substitutions and deletions in
the zinc finger domains resulted in the loss of protein activity.
To test the structural and folding predictions of the zinc finger
model, peptides encompassing each of the ADR1 fingers were
synthesized (ADRia and ADRib) as well as a mutant finger
peptide (del138) deleted for a single amino acid residue. The
folding and metal-binding characteristics ofthese were assessed
by 'H nuclear magnetic resonance (NMR) and visible spectros-
copy. While a single unique conformational species was de-
tected for the iwo wild-type peptides upon tetrahedral binding
of zinc, the deletion peptide did not bind zinc with tetrahedral
geometry, nor did it fold into a zinc finger domain. The
metal-binding and folding results found with the mutant pep-
tide were similar to those obtained when thiol alkylation or
imidazole protonation ofthe wild-type peptides was performed.
These data indicate that ligand spacing and both thiol and
imidazole participation in zinc binding are specific and neces-
sary requirements for zinc finger folding, which provides direct
support for the initial predictions of the model.
Subsequent to the proposal of the "zinc finger" model (1, 2),
amino acid sequences similar to those found in the Xenopus
transcription factor TFIIIA have been found in a variety of
putative and demonstrated eukaryotic nucleic acid binding
proteins. The zinc finger domains have been implicated as
containing the residues responsible for sequence-specific
DNA binding, though it appears that for proteins containing
many fingers, multiple finger contacts are required for base-
specific recognition and binding (3-5). ADR1 is a transcrip-
tion factor that activates expression of the glucose-repressed
alcohol dehydrogenase 2 (ADH2) gene in Saccharomyces.
The transcription factor contains two adjacent zinc finger
motifs between residues 102 and 159. An ADR1-,B-
galactosidase fusion protein containing residues 17-229 binds
specifically to a 22-base-pair dyad in the ADH2 promoter,
whereas a deletion fusion protein containing residues 17-150
could not (6). This type of deletion analysis as well as genetic
analyses and site-directed mutagenesis of some of the zinc
finger proteins (3, 7, 8) strongly supported the zinc finger
model, as did preliminary circular dichroism and NMR
spectroscopic studies of a single zinc finger peptide (9, 10).
To solve the structure of a zinc finger domain, it was first
necessary to ascertain whether peptides corresponding to
zinc finger sequences fold in vitro into a single conforma-
tional form upon the addition of metal ions. Once the repro-
ducible folding and unfolding of single-finger peptides could
be achieved and monitored by circular dichroism (CD) and
nuclear magnetic resonance (NMR) spectroscopy (9, 10)
several issues could be addressed. Do different single-finger
peptides fold into similar or identical structures? What ele-
ments ofthe primary sequences ofthe peptides are absolutely
required for proper folding into a domain? To address these
questions, three different zinc finger peptides, ADRia,
ADRib, and del138, were synthesized (Fig. 1), and their
metal-binding geometry and folding were studied. A low-
resolution model of a single-finger peptide, ADRla (10), and
a higher-resolution distance geometry structure of another,
ADRlb (11), have been determined and are reported else-
where. The wild-type zinc finger structures that we have
determined consist of an N-terminal loop involving the two
conserved cysteine residues, a C-terminal amphiphilic a-
helix, and a tightly packed hydrophobic core. The structure
ofa 25-residue peptide corresponding to 1 ofthe 37 zinc finger
domains from the Xenopus protein Xfin (Xfin-31) was re-
ported (12); this peptide has structural features similar to
those described for the ADR1 fingers.
In this report, we present the metal-binding and folding
properties of a deletion peptide in which spacing between
pairs of ligands has been altered. To ascertain the fundamen-
tal components of the primary sequence necessary for do-
main folding, we have also studied the effect of chemical
modification of ligand residues on wild-type zinc finger
folding.
MATERIALS AND METHODS
Materials. Peptide synthetic reagents were obtained from
Applied Biosystems. Vinylpyridine was obtained from Ald-
rich. Iodoacetamide and all other reagents and buffers were
from Sigma. Deuterated Tris buffer was from MSD Isotopes
and all other deuterated solvents were from Sigma.
Peptide Synthesis. Peptides (ADRia, ADRlb, de1138) were
synthesized by the stepwise solid-phase technique (13, 14).
They were purified by preparative reverse-phase HPLC, and
sequences and composition were confirmed by amino acid
compositional analysis, peptide sequencing, and mass spec-
trometry.
Peptide Folding. Subsequent to purification and lyophiliza-
tion, peptides were dissolved in 50 mM Tris acetate or
deuterated Tris acetate buffer containing either 1 mM EDTA
or a stoichiometric amount of ZnC12 at pH 7.5. The samples
were warmed to 70°C, allowed to cool to room temperature,
and stored at 4°C. To prevent oxidation, samples were stored
lyophilized and/or purged with argon.
Thiol Alkylation. Thiol groups were alkylated with iodoa-
cetamide as previously described (15). Alkylated peptide
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FIG. 1. Amino acid sequence
(standard one-letter symbols) of
zinc fingers in ADR1 and the se-
quences of the single-finger pep-
tides between residues 102 and
159 in the ADR1 protein. Se-
quences of the peptides ADRla
and ADRib are bracketed and
del138 (ADRia lacking N-138) is
denoted by an unfilled arrow.
Filled arrows point to single-finger
missense mutant peptides. Circles
indicate invariant and highly con-
served residues.
(ADRlbalk) was purified from reagents by reverse-phase
HPLC. Thiol quantitation was by amino acid compositional
analysis of pyridylethylcysteine (16).
One-Dimensional (1D) 1HNMR Spectroscopy. Proton NMR
spectra of 2H20 solutions were obtained on a Bruker AM500
at 250C with a spectral width of6410 Hz and a relaxation delay
of 1.5 s. For pH titrations, peptide concentrations were 1 mM
in 50 mM deuterated Tris acetate/25 mM deuterated acetic
acid, and 2 gl of 4% 2HC1 solution was added for each
titration point over the range of pH 7.8-3.0.
CD Spectroscopy. CD experiments were conducted at 21°C
on an Online Systems (Jefferson, GA) modified Cary 61
spectropolarimeter. Peptide concentrations were 0.25 mM in
50 mM Tris Cl and spectra were obtained with a 0.05-cm path
length.
Cobalt Visible Spectrophotometry. Ultraviolet and visible
light spectra of cobalt-peptide adducts were obtained on a
Beckman DU50 UV-Visible spectrophotometer at 21°C. The
spectrum was scanned at 500 nm/min from 800 to 200 nm.
Peptide concentrations were 0.25 mM in 50 mM Tris and
spectra were obtained with a 1-cm path length.
RESULTS
Role of Cysteine Ligands in Folding. It has been clearly
shown for ADRia (10) as well as another zinc finger peptide
(9) that Zn2+ is tetrahedrally bound. In the case of the zinc
finger protein TFIIIA (17), extended x-ray absorption fine
structure spectroscopy (EXAFS) has shown that cysteine and
histidine residues are the ligands that bind zinc with tetrahe-
dral geometry. To ascertain whether cysteine residue binding
ofZn2+ is absolutely required for the finger peptide to fold, the
thiol moieties were blocked by alkylation. In Fig. 2, the 1D 1H
NMR spectra of ADRlbalk is shown in the presence (Fig. 2,
spectrum c) and absence (Fig. 2, spectrum b) of Zn2+. For
comparison, the spectrum of unmodified ADRlb is shown in
Fig. 2, spectrum a. As with ADRla (10), when ADRlb is
reconstituted in the presence of Zn2+ (Fig. 2, spectrum a), C-2
and C-4 proton lines ofthe three histidine residues have shifted
from their positions when the peptide is reconstituted in the
presence of EDTA (11). There is as well considerable rear-
rangement of other aromatic resonances, CG proton reso-
nances, and methyl proton resonances, indicating that the
peptide is folded. In Fig. 2, spectrum b, sharp lines and the lack
of any upfield-shifted methyl peaks or downfield-shifted Ca
proton peaks indicate that ADRlbalk is not folded when
reconstituted in the absence of zinc. Upon the addition of a
stoichiometric amount of Zn2+ (Fig. 2, spectrum c), the
spectrum still shows no evidence of folding. Rather, the entire
spectrum broadens, which could be a consequence of ex-
change broadening (Zn'+-peptide exchange rate is increased
relative to the slow exchange behavior observed when thiols
are not alkylated), or ofpeptide aggregation mediated by Zn2+
binding to histidine residues. Upon the addition of excess
Zn2 , the spectrum broadens further (data not shown). We
have performed Zn2+ titrations on another thiol-alkylated
peptide (ADRlaalk) with similar results.
CD spectroscopy confirms that Zn2+ addition to ADRlbalk
was not coincident with secondary structural changes in the
peptide (data not shown). This is in contrast to TFIIIA-2 (9),
a
ppm
FIG. 2. 500-MHz 'H NMR spectra indicating the effect of cys-
teine residue alkylation on folding. One-dimensional NMR spectra
(2H20 solvent) are shown of 1 mM unmodified ADRlb reconstituted
in 1.1 mM ZnC12 and 50 mM Tris acetate, pH 7.5 (a), 1 mM ADRlbalk
reconstituted in 50 mM Tris acetate, pH 7.5 (b), and 1 mM ADRlbalk
reconstituted in 1.0 mM ZnCI2 and 50 mM Tris acetate (c). Histidine
C-2 protons are indicated by * in spectrum a.
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ADRia (10), and ADRib (data not shown), where the addi-
tion of Zn2+ resulted in a significant increase in a-helical
content in the peptide. In the case of unmodified ADRib and
ADRia, two-dimensional NMR nuclear Overhauser en-
hancement spectroscopy experiments confirmed the exis-
tence of an a-helix in both peptides (10, 11) and identified the
residues involved in the helix, which includes both conserved
histidine residues. Thus, it appears that cysteine residue
alkylation abolishes the ability of the a-helix of zinc finger
peptides to form even when histidine residues are free to
participate in Zn2+ binding.
Role of Histidine Ligands in Folding. To study the role of the
His residues in the zinc-mediated folding of these peptides,
advantage was taken of the well-resolved His C-2 proton
peaks in the 1D 1H NMR spectrum of ADRia. The ADRia
peptide contains two His residues. When folded in the
presence of Zn2 , the imidazole C-2 and C-4 proton reso-
nances from His-150 and His-155 shift and occupy unique
chemical shift positions (ref. 10 and Fig. 3). The Ca proton
and methyl proton peaks which have shifted relative to the
zinc-free spectrum also confirm that ADRia is in a folded
state. These proton peaks can be followed as a function ofpH
as is shown in Fig. 3. As the pH of the solution is decreased,
the imidazole C-2 and C-4 proton resonances do not shift.
Instead, as the pH is lowered below 5.5, proton peaks begin
to decrease in intensity, while peaks at the chemical shift
positions of the "unfolded" form increase in intensity (shown
by the filled arrows). Thus, under these conditions, the
peptide exists in two states, unfolded and folded, that are in
slow exchange (interconversion between folded and unfolded
states is slow on the chemical shift time scale). The fact that
the imidazole resonances do not shift as a function of pH
indicates that a species in which protonated imidazoles are
bound to the zinc ion is short-lived and/or is populated at a
low level. That is, protons appear to be competing with Zn2+
for imidazole, indicating that only the unprotonated imida-
zole groups serve as ligands for Zn2+ in the peptide. Once
protonated (Fig. 3, spectra d-f), the imidazole peaks shift
with decreasing pH (protonated and unprotonated imidazole
in fast exchange or interconversion between protonated and
unprotonated forms is fast on the chemical shift time scale)
in the same manner as unfolded ADRia (i.e., with a pKa of
6.2; data not shown).
Since the states of ADRla are in slow exchange, the peak
intensities for each of the forms are a direct measurement of
the fractional populations in each state. A plot of C-2 proton
peak intensity vs. pH yields an apparent pK of 5.2. This
apparent pK is the midpoint value for the overall pH-
dependent unfolding process-i.e.,
Pf-His2fZn2+ + 2H+ T P'-His2 2H+ + Zn2+
where Pf and PI represent the folded and unfolded species,
respectively. The process can be described as a competition
between Zn2+ and H+ for the free imidazole groups and the
observed or apparent pK of 5.2 is the pH at which half the
population is zinc bound (and folded) and half the population
is protonated (and unfolded).
The fractional populations of the two states can also be
plotted in a Hill plot. Hill plots for the C-2 proton peaks of the
two histidines gave Hill coefficients of 2, indicating that the
pH-dependent unfolding is a cooperative process (18). The
simplest interpretation is that once one of the imidazole
groups is protonated, the other becomes much easier to
protonate.
As illustrated in Fig. 3, the histidine resonances are not the
only ones to decrease in intensity with decreasing pH; the
same behavior is observed for the downfield-shifted Ca
protons and the upfield-shifted methyl protons (shown by the
pH f
f 3.9
e4.0K
d 4.2
C 4.9
b 6.5
80 60 40
ppm
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FIG. 3. 500-MHz 'H NMR spectra of pH titrations of ADRia.
ADRia was reconstituted at 1 mM in the presence of 1.1 mM ZnC12,
50 mM Tris acetate, and 25 mM acetic acid (deuterated buffers) at the
indicated pH values. Filled arrows point to the chemical shift
positions of the titrating "unfolded" C-2 proton resonances. Unfilled
arrows point to "folded" methyl proton peaks. His C-2 protons are
indicated by * in spectrum a.
unfilled arrow). The Ca proton resonances (downfield of the
'H20 resonance at 4.6 ppm) have been assigned to residues
Tyr-132, Cys-137, and His-155, and the methyl resonances, to
residues Ile-154 and Leu-136 (see Fig. 1). Their particular
chemical shifts are a direct consequence of both the second-
ary and tertiary structure of the folded peptide and provide a
monitor for the existence of the N-terminal cysteine loop.
The observation that these resonances disappear in concert
with the disappearance of the shifted histidine resonances
indicates that the unfolding of the peptide is a cooperative
process-that is, the cysteine loop does not remain intact
once the histidines are incapable of binding Zn2 .
Deletion Peptide deI138 vs. ADRia and ADRib. We have
chemically synthesized mutant single-finger peptides (Fig. 1)
corresponding to missense mutants in the protein ADR1 that
have decreased DNA-binding activity, to solve their struc-
tures as well as for their utility in the assignment process. The
first mutant peptide that was synthesized and studied is
de138 (Fig. 1) which is essentially ADRla lacking residue
Asn-138. The deletion of Asn-138 alters the spacing between
Cys and His residues, which is absolutely conserved (12
residues) among all zinc finger sequences of the TFIIIA
category identified to date. The conserved aliphatic and
aromatic groups as well as the Cys and- His ligands are intact
and, according to the zinc finger model, the peptide should be
capable of binding Zn2+ and folding into a domain similar to
ADRla. Certainly, in terms of steric hindrance, 11 residues
Biochemistry: Pdrraga et al.
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provide enough space for a loop or turn between the Cys and
His residues. The folding of del138 was monitored by iD 1H
NMR and CD spectroscopy, while its metal-binding proper-
ties were assayed by visible spectrophotometry. Fig. 4 shows
visible spectra of cobalt-peptide adducts ofADRia, ADRib,
and de1138. The spectra of both ADRla and ADRib contain
an absorbance maximum centered at 635 nm which is char-
acteristic of tetrahedral coordination of Co2+ (19). In con-
trast, when de1138 is reconstituted with CoCl2 (Fig. 4), it does
not bind the metal with tetrahedral geometry; the visible
spectrum lacks the absorbance maxima at 635 nm character-
istic of d-d transitions in the cobalt electron orbitals. Though
Cys and His ligands are present and chemically able to
participate in metal binding, tetrahedral binding of Co2+ does
not occur, which strongly suggests that tetrahedral coordi-
nation of Zn2` does not occur either.
Because it was clear that del138 was incapable of binding
Co2+ tetrahedrally under conditions that allowed the two
wild-type peptides to do so, we were interested in assessing
what conforiational changes, if any, occurred when del138
was reconstituted in the presence of other metals, regardless
of the exact geometry of metal binding. Fig. 5 shows iD 1H
NMR spectra of a zinc titration experiment with del138. The
deletion peptide was reconstituted in the absence ofZn2+ (Fig.
5, spectrum a), the presence of 0.25 equiv of Zn2+ (Fig. 5,
spectrum b), and the presence ofexcess Zn2+ (Fig. 5, spectrum
c). In the absence of Zn2+, the spectrum exhibits sharp
lines-in particular, the C-2 and C4 imidazole proton lines are
sharp, and both His residues occupy the same C-2 1H and C-4
1H chemical shift positions, indicating that the peptide is
unfolded and not aggregated due to oxidation. When 0.25
equiv of Zn2+ is added, the entire spectrum broadens. This is
most obvious in the aromatic region of the spectrum, espe-
cially at the imidazole chemical shift positions. When excess
Zn2+ is added, the spectrum broadens even further (Fig. 5,
1.
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FIG. 4. Visible absorption spectra of ADR1 peptides with Co2+.
*, Spectrum of 250FM ADRla or ADRlb reconstituted with 250
/AM CoC12. Additional CoCl2 was added to 10-fold excess with no
changes in the spectrum. A, Spectrum of 250,uM de1138 reconstituted
in the presence of 250 iM CoCI2. A CoCI2 titration was also
performed in single equivalent steps from 0.5- to 5.5-fold excess
CoCl2 with no change in the spectrum.
spectrum c). This titration experiment was repeated with
del138 concentrations of 0.25 mM and 5 mM at 250C and 35TC.
The results were the same in all cases. The broad 1D 1H NMR
spectra suggest that, as was the case with ADRlbalk, the
addition of Zn2+ to del138 does not drive the folding of the
peptide to a single conformation. Rather, zinc addition medi-
ates an exchange process between the peptide and zinc (in-
termediate zinc-peptide exchange) and/or aggregation of the
peptide, either of which would result in broadened proton
resonance lines. CD spectroscopy strengthens the notion that
stable domains are not being formed. When Zn2+, Cd2+, and
Co2+ titrations ofdel138 were monitored by CD spectroscopy;
no secondary structural changes of the type detected for both
ADRia (10) and ADRib (data not shown) were observed.
Therefore visible, NMR, and CD spectroscopies confirm that
del138 does not bind metals with tetrahedral geometry nor
does it fold into a stable domain structure.
DISCUSSION
The work of Frankel et al. (9) and our own work (10) indicated
that tetrahedral metal binding by zinc finger peptides was
concomitant with secondary and tertiary structural changes,
suggesting that metal binding closely parallels the folding of
the peptides. There were no previous indications that 30-
residue peptides (corresponding to interior sequences of
proteins) could be folded into stable protease-resistant do-
mains suitable for structural studies. Because of the ex-
tremely compact and stable nature of the domains, we were
interested in identifying the features of the primary sequence
required for independent folding.
If Zn2+ binding could direct the folding of zinc finger
domains, then modification of ligands should abrogate the
ability to fold and/or effectuate the unfolding of the peptides.
In this report, we have shown that when imidazole nitrogen
atoms are protonated or thiols are carboxymethylated, the
zinc finger sequences unfold and are incapable of folding,
respectively. Thus, the folded solution structures that have
been solved by NMR spectroscopy (10-12) absolutely de-
pend on the presence of reduced unblocked thiols and
unprotonated imidazole nitrogen atoms.
A major component of the folded structure of ADRla and
ADRib is the C-terminal a-helix (10, 11), which can be easily
monitored by CD spectroscopy. We can conclude from CD
and NMR spectra of the carboxymethylated peptides
ADRibalk and ADRlaalk that the C-terminal a-helix does
not form upon the addition of zinc, even though histidine
residues are capable of binding zinc. Similarly, when histi-
dine residues are protonated, NMR spectra indicate that the
entire domain unfolds even though the cysteine residues are
still capable of binding zinc. Taken together, these findings
indicate that under experimental conditions there is no evi-
dence of partially folded domains, suggesting that the folding
process involves a two-state cooperative transition.
Although it is generally acknowledged that the nature of
metal ligands is conserved among zinc fingers, it is often
overlooked that spacing between ligands is also conserved.
The distance between the pair of Cys ligands is 2-4 residues
and between the pair of His ligands it is 3 or 4 residues (but
never fewer than 3 residues, possibly to accommodate the
a-helix and/or bulky His side chains). Although there is some
flexibility in the spacing requirements between the pair of
Cys ligands and between the pair of His ligands, the distance
between the most C-terminal Cys and N-terminal His resi-
dues is absolutely conserved at 12 residues. The possible
importance of this sequence conservation is demonstrated by
our results with the deletion peptide del138. Under conditions
where both wild-type zinc finger peptides bound zinc and
folded into domains, the deletion peptide was neither capable
of binding zinc tetrahedrally nor capable of stable folding.
...
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FIG. 5. One-dimensional NMR
1H NMR spectra of del138. Spec-
tra (2H20 solvent) are shown of 1
mM dell38 reconstituted in 50mM
o a Tris acetate (a), 1 mM del138 re-
constituted with 0.25 mM ZnC12 in
50 mM Tris acetate (b), and 1 mM
del138 reconstituted with 1.5 mM
ZnC12 in 50 mM Tris acetate (c).
de1138 contains five possible Zn2+ ligands (Fig. 1). In addition
to altering conserved spacing between ligands, the deletion of
Asn-138 alters the wild-type sequence as well, bringing a
third possible thiol ligand (Cys-140) into the proximity of
Cys-137 and Cys-134. In the NMR solution structure of
ADRia (10) the thiol of Cys-140 is directed out into the
solvent, well away from Cys-134 and Cys-137 and the zinc
metal ion. The sequential proximity of three possible thiol
ligands at the N terminus of the domain may act to complicate
the folding "choices" of the peptide, rendering tetrahedral
liganding and ultimately proper folding impossible under
these conditions. This possibility is consistent with the visible
spectroscopy data indicating that del138 does not bind metal
ions tetrahedrally. Another explanation for these results is
that we have altered the apposition of the conserved Phe and
Leu residues as well as other residues that are interacting in
the central hydrophobic pocket observed in the structure of
the wild-type peptides ADRia (10) and ADRlb (11). This
could have the effect of decreasing the stabilization of the
structure by the hydrophobic core.
It should be informative to assess the metal-binding and
folding characteristics as well as the structures of other
mutant (missense) single-finger peptides from ADR1. No
missense point mutants containing alterations of conserved
aromatic and aliphatic residues (Tyr, Phe, Leu) could be
isolated in a preliminary genetic analysis of ADR1 (3).
However, site-directed mutagenesis of these residues should
allow us to assess the structural and functional significance of
the hydrophobic core in the folded zinc finger structure. In
conjunction with functional assays of the mutant proteins in
vivo and in vitro this type of analysis should afford us a better
understanding of the determinants of both zinc finger folding
and DNA binding.
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